Paroxysmal nocturnal hemoglobinuria epidemiology and demographics
Paroxysmal nocturnal hemoglobinuria Microchapters |
Differentiating Paroxysmal nocturnal hemoglobinuria from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paroxysmal nocturnal hemoglobinuria epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
FDA on Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
CDC on Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
Paroxysmal nocturnal hemoglobinuria epidemiology and demographics in the news |
Blogs on Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
Directions to Hospitals Treating Paroxysmal nocturnal hemoglobinuria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of paroxysmal nocturnal hemoglobinuria is approximately 0.13 per 100,000 individuals worldwide.[1]
Age
- Paroxysmal nocturnal hemoglobinuria commonly affects adults. However, some cases of PNH in the childhood have been reported.[2]
Race
- There is no racial predilection to [disease name].
Gender
- Paroxysmal nocturnal hemoglobinuria affects men and women equally.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Borowitz MJ, Craig FE, Digiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR; et al. (2010). "Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry". Cytometry B Clin Cytom. 78 (4): 211–30. doi:10.1002/cyto.b.20525. PMID 20533382.
- ↑ Curran KJ, Kernan NA, Prockop SE, Scaradavou A, Small TN, Kobos R; et al. (2012). "Paroxysmal nocturnal hemoglobinuria in pediatric patients". Pediatr Blood Cancer. 59 (3): 525–9. doi:10.1002/pbc.23410. PMID 22147651.